SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-17-010498
Filing Date
2017-07-19
Accepted
2017-07-19 17:32:11
Documents
2
Period of Report
2017-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 4409
2 POWER OF ATTORNEY ex24ysios.htm EX-24 14726
  Complete submission text file 0001179110-17-010498.txt   20724
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TRAVESSERA DE GRACIA 11 8TH FLOOR BARCELONA U3 08021
Business Address TRAVESSERA DE GRACIA 11 8TH FLOOR BARCELONA U3 08021 34 93 517 35 45
Ysios BioFund I FCR (Reporting) CIK: 0001711008 (see all company filings)

State of Incorp.: U3 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38150 | Film No.: 17972959